1,226 results on '"Stunnenberg, Hendrik G."'
Search Results
2. Dual targeting of cancer metabolome and stress antigens affects transcriptomic heterogeneity and efficacy of engineered T cells
3. Trained innate immunity, long-lasting epigenetic modulation, and skewed myelopoiesis by heme
4. Longitudinal single-cell transcriptomics reveals distinct patterns of recurrence in acute myeloid leukemia
5. Single cell transcriptomic analysis of the immune cell compartment in the human small intestine and in Celiac disease
6. CBX2 shapes chromatin accessibility promoting AML via p38 MAPK signaling pathway
7. Regulome analysis in B-acute lymphoblastic leukemia exposes Core Binding Factor addiction as a therapeutic vulnerability
8. Antiviral responses induced by Tdap-IPV vaccination are associated with persistent humoral immunity to Bordetella pertussis
9. Blood monocyte transcriptome and epigenome analyses reveal loci associated with human atherosclerosis
10. Mutational mechanisms shaping the coding and noncoding genome of germinal center derived B-cell lymphomas
11. Antiviral responses induced by Tdap-IPV vaccination are associated with persistent humoral immunity to Bordetella pertussis
12. Dual targeting of cancer metabolome and stress antigens affects transcriptomic heterogeneity and efficacy of engineered T cells
13. Genome-wide modelling of transcription kinetics reveals patterns of RNA production delays
14. G1-phase progression in pluripotent stem cells
15. Extensive patient-to-patient single nucleus transcriptome heterogeneity in pheochromocytomas and paragangliomas.
16. The Organoid Cell Atlas
17. Dynamics of genome architecture and chromatin function during human B cell differentiation and neoplastic transformation
18. Rewiring of glucose metabolism defines trained immunity induced by oxidized low-density lipoprotein
19. p120-catenin-dependent collective brain infiltration by glioma cell networks
20. Whole-genome fingerprint of the DNA methylome during human B cell differentiation
21. Inference of RNA Polymerase II Transcription Dynamics from Chromatin Immunoprecipitation Time Course Data
22. Dual targeting of cancer metabolome and stress antigens affects transcriptomic heterogeneity and efficacy of engineered T cells
23. Epigenetic modulation of a hardwired 3D chromatin landscape in two naive states of pluripotency
24. International network of cancer genome projects
25. International network of cancer genome projects.
26. Uric acid priming in human monocytes is driven by the AKT–PRAS40 autophagy pathway
27. Spic regulates one-carbon metabolism and histone methylation in ground-state pluripotency
28. STARR-seq identifies active, chromatin-masked, and dormant enhancers in pluripotent mouse embryonic stem cells
29. The translational landscape of ground state pluripotency
30. Dynamic CpG methylation delineates subregions within super-enhancers selectively decommissioned at the exit from naive pluripotency
31. Glutaminolysis and Fumarate Accumulation Integrate Immunometabolic and Epigenetic Programs in Trained Immunity
32. The reference epigenome and regulatory chromatin landscape of chronic lymphocytic leukemia
33. Supplementary Figure 1 from Dual Promoter Usage as Regulatory Mechanism of let-7c Expression in Leukemic and Solid Tumors
34. Supplementary Tables S1-S4 and Supplementary Figures S1-S12 from Digitalis-like Compounds Facilitate Non-Medullary Thyroid Cancer Redifferentiation through Intracellular Ca2+, FOS, and Autophagy-Dependent Pathways
35. Supplementary Table 1 from Death Receptor Pathway Activation and Increase of ROS Production by the Triple Epigenetic Inhibitor UVI5008
36. Data from Digitalis-like Compounds Facilitate Non-Medullary Thyroid Cancer Redifferentiation through Intracellular Ca2+, FOS, and Autophagy-Dependent Pathways
37. Supplementary Figure 1 from Death Receptor Pathway Activation and Increase of ROS Production by the Triple Epigenetic Inhibitor UVI5008
38. Data from Death Receptor Pathway Activation and Increase of ROS Production by the Triple Epigenetic Inhibitor UVI5008
39. Supplementary Figure 4 from Death Receptor Pathway Activation and Increase of ROS Production by the Triple Epigenetic Inhibitor UVI5008
40. Supplementary Figure Legends from Dual Promoter Usage as Regulatory Mechanism of let-7c Expression in Leukemic and Solid Tumors
41. Supplementary Figure 2 from Death Receptor Pathway Activation and Increase of ROS Production by the Triple Epigenetic Inhibitor UVI5008
42. Supplementary Figures 2 - 3 from Dual Promoter Usage as Regulatory Mechanism of let-7c Expression in Leukemic and Solid Tumors
43. Data from Dual Promoter Usage as Regulatory Mechanism of let-7c Expression in Leukemic and Solid Tumors
44. Supplementary Methods from Death Receptor Pathway Activation and Increase of ROS Production by the Triple Epigenetic Inhibitor UVI5008
45. Supplementary Figure 5 from Death Receptor Pathway Activation and Increase of ROS Production by the Triple Epigenetic Inhibitor UVI5008
46. Supplementary Figure 3 from Death Receptor Pathway Activation and Increase of ROS Production by the Triple Epigenetic Inhibitor UVI5008
47. Supplementary Table 1 from Dual Promoter Usage as Regulatory Mechanism of let-7c Expression in Leukemic and Solid Tumors
48. Supplementary Table 2 from c-Myc Modulation and Acetylation Is a Key HDAC Inhibitor Target in Cancer
49. Supplementary Figure 3 from c-Myc Modulation and Acetylation Is a Key HDAC Inhibitor Target in Cancer
50. Supplementary Figure 5 from c-Myc Modulation and Acetylation Is a Key HDAC Inhibitor Target in Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.